Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01217385 · ClinicalTrials.gov registry record · NA
Monitoring and Predicting Chemotherapy Response Using DOSI
A NA study, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01217385 is a NA study that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 60 participants.
The verdict
NCT01217385, a NA study, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
RATIONALE: New imaging procedures, such as diffuse optical spectroscopy imaging, may help measure a patient's response and allow doctors to plan better treatment. PURPOSE: This clinical trial studies diffuse optical spectroscopy imaging in monitoring and predicting response in patients with locally advanced breast cancer undergoing chemotherapy before surgery.
Interventions
- PROCEDURE DOSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01217385
The ClinicalTrials.gov registry entry for NCT01217385 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DOSI is the first listed.
NCT01217385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01217385 about?
NCT01217385 is a clinical study titled "Monitoring and Predicting Chemotherapy Response Using DOSI". RATIONALE: New imaging procedures, such as diffuse optical spectroscopy imaging, may help measure a patient's response and allow doctors to plan better treatment. PURPOSE: This clinical trial studies diffuse optical spectroscopy imaging in monitoring and predicting response in patients with locally...
What is the current status of trial NCT01217385?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-06. Estimated completion is 2014-10-06.
What interventions are being tested in trial NCT01217385?
The interventions under investigation include: DOSI (PROCEDURE).
Who is sponsoring clinical trial NCT01217385?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.